Pharma News India

The drug firm plans to focus on biologics and proprietary products over 3-4 years.

New Delhi, April 11, 2014: Dr Reddy's Laboratories plans to invest close to US$ 400 million on R&D over the next 3-4 years. The investment will focus on biologics and proprietary products as the company expects a wave of big growth in this segment.


The deal makes the new entity India's largest and world's fifth largest drugmaker.

New Delhi, April 7, 2014: Indian drug firm Sun Pharma will acquire Ranbaxy Laboratories from Daiichi Sankyo for US$ 3.2 billion. It may be noted here that the deal will make the new entity India's largest and world's fifth largest drugmaker.


The company plans to launch the product in the next few months.

New Delhi, April 3, 2014: Venus Remedies has received marketing authorisation for meropenem, an antibiotic drug, from Venenzula. The company plans to launch the product in the Latin American market in the coming few months.


The tablets are used for reducing cholesterol.

New Delhi, March 25, 2014: Indian drug firm Lupin Ltd has launched its generic version of the Niaspan extended release tablets in the US market. The tablets are used for reducing cholesterol.


The generic version of Roche's Tamiflu, this drug is used to prevent and cure flu.

New Delhi, March 18, 2014: Natco Pharma has announced that the company has received tentative approval from the US health regulator to sell the generic version of Roche's Tamiflu. It may be noted here that the drug is used to treat and prevent flu.


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...